Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 112
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II-III Chemotherapy with Hexamethylmelamine and L-Phenylalanine Mustard for Stage III and IV Ovarian Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
DFCI-75118
2.
Phase II-III HMM vs FAC (5-FU/ADR/CTX) Chemotherapy for Advanced Transitional Cell Bladder Cancer with Impaired Renal Function
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
NCI
SWOG-7904
SWOG-7904
3.
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 65
WCCC-CO-7711R
NCI-D80-048-183
4.
CACP/HMM vs CACP/HMM/MPA for Advanced Epithelial Ovarian Tumor - A Phase III Study
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI-D79-019-073
BUCRC-751
Last Modified:
6/1/2000
 
First Published:
11/1/1998
5.
Phase III Randomized Study of Intraperitoneal AD 32 Versus Oral Altretamine in Patients with Refractory or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Who Have Failed Platinum and Paclitaxel Chemotherapy (Summary Last Modified 06/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
ANTHRA-A9503
6.
Phase III Study of Chemotherapy with ADR/CCNU/HMM/MTX and Amphotericin B for Advanced non-Small Cell Bronchogenic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
CHNMC-COH-CA-LUN-1
NCI-D80-035-131
Last Modified:
7/19/2007
7.
Phase III CTX/ADR/VCR Therapy Alone or with Radiotherapy Followed by VP-16/HMM or MTX/CF/VP-16/HMM for Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 75
SEG-78LUN328
8.
Phase III Sequential Chemotherapy with CTX, HMM, ADR for Recurrent or Advanced Squamous Cell Carcinoma of the Cervix
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MDAR-30
9.
Phase III Combination Chemotherapy with L-PAM/CACP vs HAC (HMM/ADR/CTX) for Epithelial Ovarian Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MDA-G-7804
10.
Phase III Single-Agent Therapy with L-PAM or CACP and Combination Chemotherapy with HMM/CTX/ADR for Advanced Stage III/IV Cancer of the Ovary
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MDAR-64
MDA-13, MDA-14
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute